Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127)
Wheeler, D.M.
Cancer ChemoTherapy Reports 59(2 Part 1): 258-259
1975
ISSN/ISBN: 0069-0112 PMID: 1149002 Document Number: 87167
Document emailed within 1 workday
Related Documents
Schwartz, H.S.; Grindey, G.B. 1973: Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression Cancer Research 33(8): 1837-1844Pan, X.Q.; Lee, R.J. 2005: In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model Anticancer Research 25(1a): 343-346
Adam, Z.; Elbl, L.; Vorlícek, J.; Hájek, R.; Tomíska, M.; Hejlová, N.; Králová, E.; Novotná, H. 1994: Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD) Vnitrni Lekarstvi 40(8): 506-512
Paracchini, L.; Jotti, A.; Bottiroli, G.; Prosperi, E.; Supino, R.; Piccinini, F. 1993: The spin trap alpha-phenyl-tert-butyl nitrone protects against myelotoxicity and cardiotoxicity of adriamycin while preserving the cytotoxic activity Anticancer Research 13(5a): 1607-1612
Von Hoff, D.D.; Layard, M. 1981: Risk factors for development of daunorubicin cardiotoxicity Cancer Treatment Reports 65(Suppl 4): 19-23
Israel, M.; Modest, E.J.; Frei, E. 1975: N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin Cancer Research 35(5): 1365-1368
Haruyama, H.; Shimazaki, C.; Nakanishi, S.; Hamami, T.; Nisio, A.; Isemura, T.; Katsume, H.; Nakagawa, M.; Ijichi, H. 1982: Cardiotoxicity of daunorubicin and aclacinomycin a in patients with acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(3): 516-521
Recalcatri, F.; Villa, A.; Belli, C. 1982: Adriamycin cardiotoxicity Giornale Italiano di Cardiologia 12(8): 612-616
Gamna, G.; Lovisetto, P.; Pochnettino, G.; Biarese, V. 1974: Adriamycin: cardiotoxicity Bollettino Della Societa Italiana di Cardiologia 19(7): 633-670
Weisburst, M.R.; Pearlman, E.S.; Capone, R.J. 1980: Doxorubicin (Adriamycin) cardiotoxicity Connecticut Medicine 44(3): 133-136
Weisburst, M.R.; Pearlman, E.S.; Capone, R.J. 1980: Doxorubicin (Adriamycin) cardiotoxicity Connecticut Medicine 44(3): 133-136
Bossa, R.; Bissoli, M.; Chiericozzi, M.; Cozzi, R.; Galatulas, I.; Salvatore, G. 1996: Reduction of adriamycin cardiotoxicity by enoximone Anticancer Research 16(1): 141-143
Fajardo, L.F.; Eltringham, J.R.; Steward, J.R. 1976: Combined cardiotoxicity of adriamycin and x-radiation Laboratory Investigation; a Journal of Technical Methods and Pathology 34(1): 86-96
Andreani, A.; Bossa, R.; Galatulas, I.; Ninci, M.A.; Rambaldi, M. 1991: Reduction of adriamycin cardiotoxicity by a new cardiotonic agent Anticancer Research 11(1): 375-377
Ramos, A.; Meyer, R.A.; Korfhagen, J.; Wong, K.Y.; Kaplan, S. 1976: Echocardiographic evaluation of adriamycin cardiotoxicity in children Cancer Treatment Reports 60(9): 1281-1284
Herrmann, H.J.; Massow, S.; Moritz, V.; Norden, C.; Kühne, C. 1987: Peculiarities of adriamycin cardiotoxicity in spontaneously hypertensive rats (SHR) Biomedica Biochimica Acta 46(8-9): S593-S596
Mettler, F.P.; Young, D.M.; Ward, J.M. 1977: Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats Cancer Research 37(8 Part 1): 2705-2713
Stathopoulos, G.P.; Malamos, N.A.; Dontas, I.; Deliconstantinos, G.; Perrea-Kotsareli, D.; Karayannacos, P.E. 1998: Inhibition of adriamycin cardiotoxicity by 5-fluorouracil: a potential free oxygen radical scavenger Anticancer Research 18(6a): 4387-4392
Bellelli, A.; Giomini, M.; Giuliani, A.M.; Giustini, M.; Lorenzon, I.; Rusconi, V.; Sezzi, M.L.; Trotta, E.; Belleli, L. 1988: Antitumor effect and cardiotoxicity of a doxorubicin-lecithin association Anticancer Research 8(1): 177-186
Van Vleet, J.F.; Ferrans, V.J.; Badylak, S.F. 1982: Effect of thyroid hormone supplementation on chronic doxorubicin (adriamycin)-induced cardiotoxicity and serum concentrations of T3 and T4 in dogs American Journal of Veterinary Research 43(12): 2173-2182